September 7, 2021
Takeda Pharmaceutical has stumbled on another problem over its cancer drug Leuplin (leuprorelin), which has been subject to shipment restrictions since last year following GMP issues, with a glitch in its manufacturing system stalling the supply of some products. The...read more